We also tested whether mAb neutralization affected C. difficile colonization burden in stool and measured pro-inflammatory chemokine CXCL1/KC and cytokine IL-6 levels in blood serum and cecum/colon tissues to assess local and systemic responses to infection. The gene discussed is CXCL1; the disease is infection.